26/09/2024
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
26/09/2024
Sep 26, 2024, 15:08 |
Blog
Mukhtasar Malcolm Alkali: Honored to meet Dan Milner at WCC
Mukhtasar Malcolm Alkali, Cancer Advocate at Medicaid Cancer Foundation, shared a post on X: ''We…
Sep 26, 2024, 15:05 |
Blog
Jill Johnson: Mays Cancer Center is seeking adults receiving treatment for blood cancer to enroll in a remote study
Jill Johnson shared a post on X: ''Mays Cancer Center is seeking adults receiving treatment…
Sep 26, 2024, 15:04 |
Insight
Stephanie Graff: Ever wondered what 'clinically meaningful' really means
Stephanie Graff shared a post on X: "Ever wondered what 'clinically meaningful' really means? We sought…
Sep 26, 2024, 14:52 |
Blog
Carmen Uscatu: Cancer isn’t fair but care should be
Carmen Uscatu, Founding Member, President at Give Life (Dăruiește Viață), shared on LinkedIn: "Reflection of this…
Sep 26, 2024, 14:52 |
Blog
OncoInfluencers to Follow on Social Media: Dr. Bhawna Sirohi
We are thrilled to feature Dr. Bhawna Sirohi as a leading figure in the oncology…
Sep 26, 2024, 14:37 |
Insight
CCTG NE2 STOPNET Neuroendocrine Study Officially Opens in Canada
The CCTG NE2 STOPNET Study: Exploring the Role of Somatostatin Analogues in Neuroendocrine Tumor Treatment…
Sep 26, 2024, 14:34 |
Blog
Yakup Ergun: Survival and recurrence rates following SBRT or surgery in operable Stage I NSCLC
Yakup Ergun, Medical Oncologist at Antalya City Hospital, shared a post on X, about recent…
Sep 26, 2024, 14:27 |
Blog
Mehdi Hamadani: Efficacy of axatilimab in chronic graft-versus-host disease
Mehdi Hamadani shared a post on X, about recent paper published in The New England…
Sep 26, 2024, 14:24 |
Blog
Ruben A. Mesa: Honored to participate in Career Development session at AACR Health Equity
Ruben A. Mesa shared a post on X: ''Honored to participate in Career Development session…
Sep 26, 2024, 14:22 |
Blog
Luis Castelo-Branco: Belzutifan vs everolimus for advanced kidney cancer
Luis Castelo-Branco shared a post on X: ''Belzutifan vs everolimus for advanced kidney cancer: NO…
3
4
5
6
7
All:
105
Posts:
41 - 50
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube